Smolensky Koganov, Elena
Michelson, Alan D.
Yanachkov, Ivan B.
Yanachkova, Milka I.
Wright, George E.
Przyklenk, Karin
Frelinger, Andrew L. III
Article History
Received: 10 April 2018
Accepted: 31 August 2018
First Online: 28 September 2018
Change Date: 29 November 2018
Change Type: Correction
Change Details: A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Competing Interests
: E. Smolensky Koganov has nothing to disclose. I. B. Yanachkov, M. I. Yanachkova and G. E. Wright, are employees of GLSynthesis, Inc. A. D. Michelson has received grant support from GLSynthesis and Lilly/Daiichi Sankyo, and served on a steering committee for an AstraZeneca clinical trial. A. L. Frelinger has received grant support from GLSynthesis and Lilly/Daiichi Sankyo. K. Przyklenk has received grant support from GLSynthesis and serves on the scientific advisory board of Infarct Reduction Technologies, Inc.